Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Caris Biorepository Research Protocol
NCT01499394 · View on ClinicalTrials.gov ↗
Study Summary
The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients. The Caris Biorepository is a repository of prospectively collected biological specimens and associated clinical and demographic data gathered from multiple sources to be stored, used and shared for research. Caris Life Sciences will maintain the data and specimens and will control access to and use of the information and specimens by multiple individuals for multiple purposes which may evolve over time.
Conditions Studied
Study Locations (20)
Florida
- Lee Memorial Health System — Fort Myers
- Cancer Care of North Florida — Lake City
- Advent Health — Orlando
- The University of South Florida — Tampa
- Cleveland Clinic Florida — Weston
Georgia
- Phoebe Putney Memorial Hospital — Albany
- Emory University — Atlanta
- Augusta University Research Institute — Augusta
- Cancer Center of Middle Georgia — Dublin
Arkansas
- St. Bernards Medical Center — Jonesboro
- CARTI Cancer Center — Little Rock
- ObjectiveHealth - ARcare Center for Clinical Research — Little Rock
Louisiana
- CHRISTUS - St. Frances Cabrini Hospital — Alexandria
- Tulane University — New Orleans
- CHRISTUS - Highland Medical Center — Shreveport
Maryland
- Mercy Medical Center — Baltimore
- Sinai Hospital of Baltimore — Baltimore
Alabama
- University of South Alabama — Mobile
Arizona
- Southwest Medical Imaging — Scottsdale
Illinois
- Hope and Healing Cancer Services — Hinsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2010-11 |
| Est. Completion | 2035-11 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01499394
The ClinicalTrials.gov registry entry for NCT01499394 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 100,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Caris Science, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT01499394 reports 20 study locations spanning 8 distinct geographic areas — top geographies include Florida, Georgia, Arkansas. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT01499394 about?
NCT01499394 is a clinical study titled "Caris Biorepository Research Protocol". The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients. The Caris Biorepository is a repository of prospectively collecte...
What is the current status of trial NCT01499394?
This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2010-11. Estimated completion is 2035-11.
What conditions does trial NCT01499394 study?
This clinical trial studies the following conditions: Cancer, Minimal Residual Disease, Early Detection of Cancer. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT01499394?
This trial is sponsored by Caris Science, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT01499394 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.